Both periodontal disease and obesity are multifactorial diseases that have been shown to increase host inflammatory burden. Furthermore, enteric bacteria, including periodontal pathogens, may play a role in nutrient absorption and metabolism. These diseases share common risk factors, inflammatory pathways, and are associated with similar comorbid medical conditions. Periodontal disease and the inflammatory burden it creates should be discussed with patients and the use of advanced therapies to control the increased inflammatory load in patients with both obesity and periodontitis should be considered.
Comanagement of patients with obesity and periodontal disease with their treating physician will allow for screening of patients for additional cormoribidities and can be used to further characterize the patients’ overall inflammatory burden (e.g., through CRP level testing) which can then inform treatment choices for oral disease treatment including personalization of the treatment plan and maintenance protocols. Counseling patients about the effects that their obesity may have on their oral condition is also an important step in encouraging patients to decrease their weight and control their overall inflammatory levels.